FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/09/057703 [Registered on: 15/09/2023] Trial Registered Prospectively
Last Modified On: 05/09/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Effect of intravenous versus perineural dexamethasone on random blood sugar in patients receiving brachial plexus block 
Scientific Title of Study   A study to compare the effect of intravenous versus perineural dexamethasone on random blood sugar in patients undergoing upper limb surgery under supraclavicular brachial plexus block 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shubhdeep 
Designation  Associate Professor 
Affiliation  Sri Guru Ram Das Institute of Medical Sciences and Research, Sri Amritsar 
Address  Main Ot complec, Department of Anaesthesia

Amritsar
PUNJAB
143001
India 
Phone  9915575859  
Fax    
Email  shubhdeepjassal@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Preet Kanwal Kaur 
Designation  Junior Resident 
Affiliation  Sri Guru Ram Das Institute of Medical Sciences and Research 
Address  Department of Anaesthesia, Sri Guru Ram Das Institute of Medical Sciences and Research, Sri Amritsar

Amritsar
PUNJAB
143001
India 
Phone  9501541361  
Fax    
Email  dr.preet2610@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ruchi Gupta 
Designation  Prof and Head 
Affiliation  Sri Guru Ram Das Institute of Medical Sciences and Research 
Address  Main OT Complex, Department of Anaesthesia

Amritsar
PUNJAB
143001
India 
Phone  9814020805  
Fax    
Email  drruchisgrd@gmail.com  
 
Source of Monetary or Material Support  
NA 
 
Primary Sponsor  
Name  Sri Guru Ram Das Institute of Medical sciences and Research 
Address  Deaprtment of Anaesthesia, Mehta Road, Vallah 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ruchi Gupta  Sri Guru Ram Das Institute of Medical Sciences and Research  Main operation theatre, mehta Road, Vallah
Amritsar
PUNJAB 
9814020805

drruchisgrd@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SGRD Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  intravenous Dexamethasone( 0.1 mg/kg ) versus perineural Dexamethasone( 0.1 mg/kg ) versus placebo  Before performing brachial plexus block till 24 hours 
Intervention  RBS monitoring after intravenous Dexamethasone( 0.1 mg/kg ) versus perineural Dexamethasone( 0.1 mg/kg ) versus placebo in patients receiving Supraclavicular brachial plexus block  Before performing brachial plexus block till 24 hours 
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1.Patients in class ASA I and II
2.Surgery planned under supraclavicular block
3.Non-Diabetic Patients  
 
ExclusionCriteria 
Details  1. Patient refusal
2. Infection at the site of injection
3. Contraindications to brachial plexus block
4. Hypersensitivity to any drug used in study
5. Pregnancy
6. Patient on anticoagulants
7. Patient on chronic/acute steroid therapy
8. Perioperative dextrose infusions
9. HbA1c >5.5
10. Weight of the patient <40kgs and >100kgs  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Difference in blood sugar levels at baseline & after four hours of administration of
dexamethasone by the perineural and intravenous route 
Before performing supraclavicular brachial plexus block then at 4hrs. 
 
Secondary Outcome  
Outcome  TimePoints 
Blood sugar levels at 2,4,8 & 24 hours after dexamethasone administration.
Duration of analgesia of the three groups
Requirement of rescue analgesia in the three groups 
Before performing supraclavicular brachial plexus block then at 2,4,8 & 24 hours  
 
Target Sample Size   Total Sample Size="105"
Sample Size from India="105" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   20/09/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="9"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Background: Brachial plexus block is the preferred choice of anaesthesia for upper limb surgeries. Local anaesthetics like lignocaine and bupivacaine are used to provide analgesia and anaesthesia. Bupivacaine is the most commonly used local anaesthetic. Various adjuvants like clonidine, dexamethasone, opioids are used to prolong regional blockade, decrease the dosage of local anaesthetic required, shorten the onset time of block and prolong the duration of post-operative analgesia. Dexamethasone has been used as a perineural adjuvant as well as intravenous analgesic and because of its glucocorticoid properties it may cause hyperglycaemia.  Objectives: To compare the difference in blood sugar levels after the administration of dexamethasone by the perineural and intravenous route in supraclavicular brachial plexus block in non-diabetic patients undergoing upper limb surgeries. Material and methods: Total of 105 patients will receive USG guided supraclavicular brachial plexus block with 25mL of 0.5% bupivacaine. They’ll be randomly allocated to one of the three study groups of 35 each. Group I: 0.1mg/kg dexamethasone diluted in 2 mL normal saline (NS) (perineural) + 100 mL NS (Intravenous); Group II: 2 mL NS (perineural) + 0.1 mg/kg dexamethasone in 100mL NS (Intravenous); Group III: 2mL NS (perineural) + 100mL NS (Intravenous). Total volume given perineurally will be 27ml. Maximum dose of dexamethasone to be used will be 6mg. Random blood sugar will be measured at baseline (T0) and then 2, 4, 8, and 24 hours after T0. Expected Benefits: This study will help us to evaluate the effect of dexamethasone on random blood sugar levels in supraclavicular block when given intravenous vs perineurally.  
Close